Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Venture North Capital is a Canada-based capital markets and investor relations consulting firm rather than a life sciences operating company. The firm appears to provide services such as strategic investor outreach, IPO and financing advisory, debt restructuring, valuation support, mergers and transaction-related consulting, and capital markets communications. Publicly available descriptions indicate that it works with growth companies, including issuers listed on Canadian exchanges, but it does not appear to develop therapeutics, diagnostics, or healthcare products itself. As a result, Venture North Capital is best categorized as a financial services and investor relations business, not a biotech, pharma, or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Venture North Capital.